NCCTG (Alliance) N0572: A phase II trial of sorafenib and temsirolimus in recurrent glioblastoma (GBM) patients who progress following prior RT/temozolomide (TMZ) and VEGF inhibitors (VEGFi).
Kurt A. Jaeckle
No relevant relationships to disclose
David Schiff
No relevant relationships to disclose
S. Keith Anderson
No relevant relationships to disclose
Evanthia Galanis
No relevant relationships to disclose
Philip J. Stella
No relevant relationships to disclose
Patrick J. Flynn
No relevant relationships to disclose
Jann Nagina Sarkaria
No relevant relationships to disclose
Caterina Giannini
No relevant relationships to disclose
Bradley J. Erickson
No relevant relationships to disclose
Jan C Buckner
No relevant relationships to disclose